Clinical Trial Update: Efficacy of Mesalazine Combined With Biologics in the Treatment of Moderate to Severe Ulcerative Colitis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating the efficacy of mesalazine combined with biologics for moderate to severe ulcerative colitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Mesalazine (mesalazine)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Ulcerative Colitis, Efficacy, Self | Phase 4 | Status: UNKNOWN